NCT00327678View on ClinicalTrials.gov

Treatment of Acute Lymphoblastic Leukemia (ALL) in Younger Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

1,080

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Leukemia, Lymphocytic
Interventions
DRUG

Rituximab

DRUG

Imatinib Mesylate

Trial Locations (1)

69

Group for Research in Adult Acute Lymphoblastic Leukemia - GRAALL -, Lyon

All Listed Sponsors
collaborator

Group for Research in Adult Acute Lymphoblastic Leukemia

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT00327678 - Treatment of Acute Lymphoblastic Leukemia (ALL) in Younger Adults | Biotech Hunter | Biotech Hunter